Improved governance and pre-release safety evaluations needed for biological AI models Post author: Post published:August 23, 2024 Post category:uncategorized Concerns over the biosecurity risks posed by artificial intelligence (AI) models in biology continue to grow. You Might Also Like Liquid biopsies can accurately detect residual disease in patients with cervical cancer, study confirms October 3, 2023 Comparative study on preventative SMA therapies shows mixed outcomes June 25, 2024 New drug targets identified for retinitis pigmentosa therapies October 16, 2024
Liquid biopsies can accurately detect residual disease in patients with cervical cancer, study confirms October 3, 2023